Jiangsu CoWin Biotech Revenue

In the year 2025, Jiangsu CoWin Biotech had annual revenue of 193.52M CNY with 53.74% growth. Jiangsu CoWin Biotech had revenue of 53.95M in the quarter ending December 31, 2025, with 95.51% growth.

Revenue

193.52M

Revenue Growth

+53.74%

P/S Ratio

11.59

Revenue / Employee

232.32K

Employees

770

Market Cap

2.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	193.52M	67.64M	53.74%
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Gdk Biological Technology	110.32M
Guiyang Xintian Pharmaceutical	749.72M
Zhejiang East Asia Pharmaceutical	940.19M
Shanghai Hile Bio-Technology	246.35M
Shanghai Universal Biotech	1.07B
Suzhou Fushilai Pharmaceutical	412.51M
Cabio Biotech (Wuhan)	418.18M
Jilin Jian Yisheng Pharmaceutical	659.66M

Revenue Rankings